6.69
price up icon3.72%   0.24
 
loading

Finanzdaten der Savara Inc-Aktie (SVRA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
8.79%
28.43
31.17 26.36 23.19 22.48
Depreciation and Amortization
6.25%
0.03
0.032 0.033 0.033 0.032
Operating Income/Loss
8.79%
-28.43
-31.17 -26.36 -23.19 -22.48
Income/Loss From Continuing Operations Before Tax
8.28%
-26.64
-29.04 -24.25 -22.24 -20.35
Income/Loss From Continuing Operations After Tax
8.31%
-26.64
-29.05 -24.25 -22.24 -20.35
Net Income/Loss
8.28%
-26.64
-29.04 -24.25 -22.24 -20.35
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,631%
216.15
5.7934 211.85 182.58 182.55
Diluted Average Shares
3,631%
216.15
5.7934 211.85 182.58 182.55
Basic Earnings Per Share
7.69%
-0.12
-0.13 -0.11 -0.12 -0.11
Diluted Earnings Per Share
7.69%
-0.12
-0.13 -0.11 -0.12 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):